2,209
Views
44
CrossRef citations to date
0
Altmetric
Research Paper

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action

, , , , , , , & show all
Pages 287-295 | Received 02 Nov 2016, Accepted 06 Feb 2017, Published online: 30 Mar 2017

References

  • Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci 2016; 10:1969-1987; PMID:26894897; http://dx.doi.org/10.1007/s00018-016-2161-x
  • Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010; 51:1820-1832; PMID:20432259; http://dx.doi.org/10.1002/hep.23594
  • McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management. J Hepatol 2015; 62:1148-1155; PMID:25477264; http://dx.doi.org/10.1016/j.jhep.2014.11.034
  • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64:73-84; PMID:26707365; http://dx.doi.org/10.1002/hep.28431
  • Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, Nguyen P, Hernandez C, Richards L, Salotti J, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 2015; 149:1784-1793; PMID:26299412; http://dx.doi.org/10.1053/j.gastro.2015.08.011
  • Watanabe S, Hashimoto E, Ikejima K, Uto H, Ono M, Sumida Y, Seike M, Takei Y, Takehara T, Tokushige K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. J Gastroenterol 2015; 50:364-377; PMID:25708290; http://dx.doi.org/10.1007/s00535-015-1050-7
  • Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 2012; 56:1145-1151; PMID:22245895; http://dx.doi.org/10.1016/j.jhep.2011.12.011
  • de Mello VD, Pulkkinen L, Lalli M, Kolehmainen M, Pihlajamaki J, Uusitupa M. DNA methylation in obesity and type 2 diabetes. Ann Med 2014; 46:103-113; PMID:24779963; http://dx.doi.org/10.3109/07853890.2013.857259
  • Gillberg L, Perfilyev A, Brons C, Thomasen M, Grunnet LG, Volkov P, Rosqvist F, Iggman D, Dahlman I, Riserus U, et al. Adipose tissue transcriptomics and epigenomics in low birthweight men and controls: Role of high-fat overfeeding. Diabetologia 2016; 59:799-812; PMID:26750116; http://dx.doi.org/10.1007/s00125-015-3852-9
  • Gallego-Duran R, Romero-Gomez M. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. World J Hepatol 2015; 7:2497-2502; PMID:26523202; http://dx.doi.org/10.4254/wjh.v7.i24.2497
  • Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med 2016; Mol Aspects Med. 2017 54:78-88; PMID:27889327; http://dx.doi.org/10.1016/j.mam.2016.11.008
  • Zeybel M, Hardy T, Robinson SM, Fox C, Anstee QM, Ness T, Masson S, Mathers JC, French J, White S, et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin Epigenetics 2015; 7:110, 25-015-0056-6. eCollection 2015; PMID:26473022; http://dx.doi.org/10.1186/s13148-015-0056-6
  • Ahrens M, Ammerpohl O, von Schonfels W, Kolarova J, Bens S, Itzel T, Teufel A, Herrmann A, Brosch M, Hinrichsen H, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab 2013; 18:296-302; PMID:23931760; http://dx.doi.org/10.1016/j.cmet.2013.07.004
  • Murphy SK, Yang H, Moylan CA, Pang H, Dellinger A, Abdelmalek MF, Garrett ME, Ashley-Koch A, Suzuki A, Tillmann HL, et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 2013; 145:1076-1087; PMID:23916847; http://dx.doi.org/10.1053/j.gastro.2013.07.047
  • Sookoian S, Rosselli MS, Gemma C, Burgueno AL, Fernandez Gianotti T, Castano GO, Pirola CJ. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology 2010; 52:1992-2000; PMID:20890895; http://dx.doi.org/10.1002/hep.23927
  • Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:e38; PMID:14973332; http://dx.doi.org/10.1093/nar/gnh032
  • Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U. Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival. Clin Epigenetics 2015; 7:110- 015-0145-6. eCollection 2015; PMID:26473022; http://dx.doi.org/10.1186/s13148-015-0145-6
  • Nilsson E, Matte A, Perfilyev A, de Mello VD, Kakela P, Pihlajamaki J, Ling C. Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels. J Clin Endocrinol Metab 2015; 100:E1491-501; PMID:26418287; http://dx.doi.org/10.1210/jc.2015-3204
  • Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, et al. Hypomethylation and hypermethylation of DNA in wilms tumors. Oncogene 2002; 21:6694-6702; PMID:12242669; http://dx.doi.org/10.1038/sj.onc.1205890
  • Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, Minamoto T, Kawakami K. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007; 98:1454-1460; PMID:17640302; http://dx.doi.org/10.1111/j.1349-7006.2007.00548.x
  • Engel T, Lueken A, Bode G, Hobohm U, Lorkowski S, Schlueter B, Rust S, Cullen P, Pech M, Assmann G, et al. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett 2004; 566:241-246; PMID:15147902; http://dx.doi.org/10.1016/j.febslet.2004.04.048
  • Hong C, Walczak R, Dhamko H, Bradley MN, Marathe C, Boyadjian R, Salazar JV, Tontonoz P. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: Identification of ARL7 as a direct target. J Lipid Res 2011; 52:531-539; PMID:21187453; http://dx.doi.org/10.1194/jlr.M010686
  • Chen J, Wang N, Dong M, Guo M, Zhao Y, Zhuo Z, Zhang C, Chi X, Pan Y, Jiang J, et al. The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection. Diabetes 2015; 64:4088-4098; PMID:26420860; http://dx.doi.org/10.2337/db15-0197
  • Staten NR, Welsh EA, Sidik K, McDonald SA, Dufield DR, Maqsodi B, Ma Y, McMaster GK, Mathews RW, Arch RH, et al. Multiplex transcriptional analysis of paraffin-embedded liver needle biopsy from patients with liver fibrosis. Fibrogenesis Tissue Repair 2012; 5:21- 1536-5-21; PMID:23270325; http://dx.doi.org/10.1186/1755-1536-5-21
  • CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013; 45:25-33; PMID:23202125; http://dx.doi.org/10.1111/j.1478-3231.2006.01312.x
  • Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 2006; 26:864-871; PMID:16911470; http://dx.doi.org/10.1111/j.1478-3231.2006.01312.x
  • Yagai T, Miyajima A, Tanaka M. Semaphorin 3E secreted by damaged hepatocytes regulates the sinusoidal regeneration and liver fibrosis during liver regeneration. Am J Pathol 2014; 184:2250-2259; PMID:24930441; http://dx.doi.org/10.1016/j.ajpath.2014.04.018
  • Arguello G, Balboa E, Arrese M, Zanlungo S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim Biophys Acta 2015; 1852:1765-1778; PMID:26027904; http://dx.doi.org/10.1016/j.bbadis.2015.05.015
  • Byrne CD, Targher G. NAFLD: A multisystem disease. J Hepatol 2015; 62:S47-64; PMID:25920090; http://dx.doi.org/10.1016/j.jhep.2014.12.012
  • Zelinski EL, Deibel SH, McDonald RJ. The trouble with circadian clock dysfunction: Multiple deleterious effects on the brain and body. Neurosci Biobehav Rev 2014; 40:80-101; PMID:24468109; http://dx.doi.org/10.1016/j.neubiorev.2014.01.007
  • Niu Y, Zhao X, Wu YS, Li MM, Wang XJ, Yang YG. N6-methyl-adenosine (m6A) in RNA: An old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics 2013; 11:8-17; PMID:23453015; http://dx.doi.org/10.1016/j.gpb.2012.12.002
  • Zigmond E, Tayer-Shifman O, Lalazar G, Ben Ya'acov A, Weksler-Zangen S, Shasha D, Sklair-Levy M, Zolotarov L, Shalev Z, Kalman R, et al. Beta-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the psammomys obesus model. J Inflamm Res 2014; 7:151-158; PMID:25336983; https://doi.org/10.2147/JIR.S50508
  • Männisto VT, Simonen M, Hyysalo J, Soininen P, Kangas AJ, Kaminska D, Matte AK, Venesmaa S, Käkelä P, Karja V, et al. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver Int 2015; 35:1853-1861; PMID:25533197; http://dx.doi.org/10.1111/liv.12769
  • Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137:959-965; PMID:8317453; http://dx.doi.org/10.1093/oxfordjournals.aje.a116768
  • Surapaneni KM, Jainu M. Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in non alcoholic steatohepatitis. Pharmacognosy Res 2014; 6:153-162; PMID:24761121; http://dx.doi.org/10.4103/0974-8490.129037
  • Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res 2008; 102:401-414; PMID:18309108; http://dx.doi.org/10.1161/CIRCRESAHA.107.165472
  • Gonzalez-Rodriguez A, Mayoral R, Agra N, Valdecantos MP, Pardo V, Miquilena-Colina ME, Vargas-Castrillon J, Lo Iacono O, Corazzari M, Fimia GM, et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis 2014; 5:e1179; PMID:24743734; http://dx.doi.org/10.1038/cddis.2014.162
  • Ke B, Zhao Z, Ye X, Gao Z, Manganiello V, Wu B, Ye J. Inactivation of NF-ΰB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP/PKA pathway. Diabetes 2015; 64:3355-3362; PMID:26038580; http://dx.doi.org/10.2337/db15-0242
  • Liu HY, Han J, Cao SY, Hong T, Zhuo D, Shi J, Liu Z, Cao W. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: Inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem 2009; 284:31484-31492; PMID:19758991; http://dx.doi.org/10.1074/jbc.M109.033936
  • Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793-1801; PMID:16823477; http://dx.doi.org/10.1172/JCI29069
  • Knowles JW, Xie W, Zhang Z, Chennemsetty I, Assimes TL, Paananen J, Hansson O, Pankow J, Goodarzi MO, Carcamo-Orive I, et al. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest 2015; 125:1739-1751; PMID:25798622; http://dx.doi.org/10.1172/JCI74692
  • Al-Share QY, DeAngelis AM, Lester SG, Bowman TA, Ramakrishnan SK, Abdallah SL, Russo L, Patel PR, Kaw MK, Raphael CK, et al. Forced hepatic overexpression of CEACAM1 curtails diet-induced insulin resistance. Diabetes 2015; 64:2780-2790; PMID:25972571; http://dx.doi.org/10.2337/db14-1772
  • Alexaki A, Gupta SD, Majumder S, Kono M, Tuymetova G, Harmon JM, Dunn TM, Proia RL. Autophagy regulates sphingolipid levels in the liver. J Lipid Res 2014; 55:2521-2531; PMID:25332431; http://dx.doi.org/10.1194/jlr.M051862
  • Kim YM, Stone M, Hwang TH, Kim YG, Dunlevy JR, Griffin TJ, Kim DH. SH3BP4 is a negative regulator of amino acid-rag GTPase-mTORC1 signaling. Mol Cell 2012; 46:833-846; PMID:22575674; http://dx.doi.org/10.1016/j.molcel.2012.04.007
  • Zoncu R, Efeyan A, Sabatini DM. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025
  • DeAngelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, et al. Carcinoembryonic antigen-related cell adhesion molecule 1: A link between insulin and lipid metabolism. Diabetes 2008; 57:2296-2303; PMID:18544705; http://dx.doi.org/10.2337/db08-0379
  • Najjar SM. Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 2002; 13:240-245; PMID:12128284; http://dx.doi.org/10.1016/S1043-2760(02)00608-2
  • Kim AY, Park YJ, Pan X, Shin KC, Kwak SH, Bassas AF, Sallam RM, Park KS, Alfadda AA, Xu A, et al. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat Commun 2015; 6:7585; PMID:26139044; http://dx.doi.org/10.1038/ncomms8585
  • Olsen AS, Sarras MP, Jr, Leontovich A, Intine RV. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 2012; 61:485-491; PMID:22228713; http://dx.doi.org/10.2337/db11-0588
  • Dhliwayo N, Sarras MP, Jr, Luczkowski E, Mason SM, Intine RV. Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation. Diabetes 2014; 63:3069-3076; PMID:24722243; http://dx.doi.org/10.2337/db13-1916
  • Hall E, Volkov P, Dayeh T, Bacos K, Ronn T, Nitert MD, Ling C. Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med 2014; 12:103- 7015-12-103; http://dx.doi.org/10.1186/1741-7015-12-103
  • Silva-Martinez GA, Rodriguez-Rios D, Alvarado-Caudillo Y, Vaquero A, Esteller M, Carmona FJ, Moran S, Nielsen FC, Wickstrom-Lindholm M, Wrobel K, et al. Arachidonic and oleic acid exert distinct effects on the DNA methylome. Epigenetics 2016; 11:321-334; PMID:27088456; http://dx.doi.org/10.1080/15592294.2016.1161873
  • Männisto VT, Simonen M, Soininen P, Tiainen M, Kangas AJ, Kaminska D, Venesmaa S, Käkelä P, Karja V, Gylling H, et al. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res 2014; 55:2676-2684; PMID:25344588; http://dx.doi.org/10.1194/jlr.P054387
  • Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474; PMID:10484010; http://dx.doi.org/10.1111/j.1572-0241.1999.01377.x
  • Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321; PMID:15915461; http://dx.doi.org/10.1002/hep.20701
  • Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-295; PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.2011.07.007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.